Action Point Financial Planning’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-10
Closed -$1.1K – 1997
2026
Q2
$1.1K Buy
+10
New +$1.04K ﹤0.01% 2457

Other funds holding PTGX

Action Point Financial Planning's PTGX Position: Q3 2026 in Review

Action Point Financial Planning sold out of Protagonist Therapeutics (PTGX) in Q3 2026, closing a stake of 10 shares — an estimated $1.1K sold.

Action Point Financial Planning first reported a position in PTGX in Q2 2026 and held it in 1 quarter. The position peaked at $1.1K in Q2 2026. 380 funds tracked by Wall St. Rank hold PTGX as of Q3 2026.

  • Action Point Financial Planning reported no remaining Protagonist Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Action Point Financial Planning sold 10 Protagonist Therapeutics shares in Q3 2026, an estimated $1.1K.
  • Action Point Financial Planning first reported a position in Protagonist Therapeutics in Q2 2026 and held it in 1 quarter.
  • Action Point Financial Planning's Protagonist Therapeutics position peaked at $1.1K in Q2 2026.
  • 380 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q3 2026.

Based on Action Point Financial Planning's 13F filing for Q3 2026, filed 13 Nov 2026.